Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Assess which is better for you: index funds or active funds, focusing on costs, performance consistency, and your investment horizon.
24,613 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
A new Nasdaq-100 strategy fund began paying weekly Friday distributions, targeting a 40% yield and challenging the tr...
As mega-cap tech pours capital into AI, investors seek signs of durable returns. This piece analyzes which firms stan...
As XRP and Cardano chase a $5 milestone, traders weigh price paths, ETF momentum, and a major Cardano upgrade set for...
Veteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
When a hedge fund takes position in a logistics stock, it often signals confidence in the sector's growth prospects a...
The 2026 Hedge Fund Alternative Manager Forum brought together leaders to share how AI, data, and differentiated stra...
UK regulators propose a narrow path for crypto exposure inside mainstream funds. A 10% cap on crypto ETNs could let m...
A major fund trimmed a sizable stake in Manhattan Associates as the stock pulled back sharply. This article breaks do...
PNC Bank has closed a $251.4 million affordable housing fund to expand the nation’s supply of affordable rentals, fin...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...